These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Topoisomerase I-mediated DNA cleavage as a guide to the development of antitumor agents derived from the marine alkaloid lamellarin D: triester derivatives incorporating amino acid residues. Tardy C; Facompré M; Laine W; Baldeyrou B; García-Gravalos D; Francesch A; Mateo C; Pastor A; Jiménez JA; Manzanares I; Cuevas C; Bailly C Bioorg Med Chem; 2004 Apr; 12(7):1697-712. PubMed ID: 15028262 [TBL] [Abstract][Full Text] [Related]
5. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Govindaraju K; Ingels A; Hasan MN; Sun D; Mathieu V; Masi M; Evidente A; Kornienko A Bioorg Med Chem Lett; 2018 Feb; 28(4):589-593. PubMed ID: 29409754 [TBL] [Abstract][Full Text] [Related]
6. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones. Mohamed MF; Hassaneen HM; Abdelhamid IA Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of Na(+),K(+)-ATPase by the extract of Stephania cephararantha HAYATA and bisbenzylisoquinoline alkaloid cycleanine, a major constituent. Satoh K; Nagai F; Ono M; Aoki N Biochem Pharmacol; 2003 Aug; 66(3):379-85. PubMed ID: 12907236 [TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and anti-hepatocellular carcinoma activity of 3-arylisoquinoline alkaloids. Deng X; Luo T; Li Z; Wen H; Zhang H; Yang X; Lei F; Liu D; Shi T; Zhao Q; Wang Z Eur J Med Chem; 2022 Jan; 228():113985. PubMed ID: 34802836 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and anticancer activity of all known (-)-agelastatin alkaloids. Han S; Siegel DS; Morrison KC; Hergenrother PJ; Movassaghi M J Org Chem; 2013 Dec; 78(23):11970-84. PubMed ID: 24152243 [TBL] [Abstract][Full Text] [Related]
10. Cytotoxic activity, apoptosis induction and structure-activity relationship of 8-OR-2-aryl-3,4-dihydroisoquinolin-2-ium salts as promising anticancer agents. Cao FJ; Zhu LF; Kuang Q; Li XQ; Zhou BH; Yang XJ; Zhou L Bioorg Med Chem Lett; 2017 Jan; 27(1):55-60. PubMed ID: 27887841 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxicity of (+/-)-7,9-dideoxy-pancratistatin analogues. Nieto-García O; Alonso R Org Biomol Chem; 2013 Jan; 11(3):515-22. PubMed ID: 23207545 [TBL] [Abstract][Full Text] [Related]
12. Mild C(sp Romo-Pérez A; Miranda LD; Chávez-Blanco AD; Dueñas-González A; Camacho-Corona MDR; Acosta-Huerta A; García A Eur J Med Chem; 2017 Sep; 138():1-12. PubMed ID: 28641156 [TBL] [Abstract][Full Text] [Related]
13. Concise total synthesis of water soluble metatacarboline A, C, D, E and F and its anticancer activity. Naveen B; Mudiraj A; Khamushavalli G; Babu PP; Nagarajan R Eur J Med Chem; 2016 May; 113():167-78. PubMed ID: 26927685 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological evaluations of novel indenoisoquinolines as topoisomerase I inhibitors. Zhang X; Wang R; Zhao L; Lu N; Wang J; You Q; Li Z; Guo Q Bioorg Med Chem Lett; 2012 Jan; 22(2):1276-81. PubMed ID: 22079759 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, anticancer activity and effects on cell cycle profile and apoptosis of novel thieno[2,3-d]pyrimidine and thieno[3,2-e] triazolo[4,3-c]pyrimidine derivatives. Kandeel MM; Refaat HM; Kassab AE; Shahin IG; Abdelghany TM Eur J Med Chem; 2015 Jan; 90():620-32. PubMed ID: 25499930 [TBL] [Abstract][Full Text] [Related]